Publication | Closed Access

Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina with Aggrastat® [tirofiban] and Determine Cost of Therapy with Invasive or Conservative Strategy)–TIMI 18 trial

Percutaneous Coronary InterventionDetermine CostHealth EconomicsHealth PolicyCardiovascular DiseaseClinical EffectivenessCost-effectiveness MethodsClinical TrialsOutcomes ResearchPharmacoeconomicsPharmacotherapyCost EffectivenessEconomic EvaluationMedicineConservative StrategyHealth Sciences